Altered brain development in an early-onset murine model of Alzheimer's disease

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 638-647

  Allemang Grand, R ^a,b   Scholz, J ^a   Ellegood, J ^a   Cahill, L S ^a   Laliberte C ^a   Fraser, P E ^b,c   Josselyn, S A ^a,b   Sled, J G ^a,b   Lerch, J P ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain development; Longitudinal magnetic resonance imaging; Mouse models of Alzheimer's disease; Neuroanatomy

Indexed keywords

MANGANESE;

ADULT; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ATROPHY; BRAIN DEVELOPMENT; BRAIN REGION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EX VIVO STUDY; FEMALE; IN VIVO STUDY; LONGITUDINAL STUDY; MALE; MOUSE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSTNATAL DEVELOPMENT; TRANSGENIC MOUSE; WILD TYPE MOUSE; AGING; ANIMAL; ATROPHY; BRAIN; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

AGING; ALZHEIMER DISEASE; ANIMALS; ATROPHY; BRAIN; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MICE, TRANSGENIC; PLAQUE, AMYLOID;

EID: 84922779082     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.08.032     Document Type: Article

References (52)

1. Apostolova L.G., Thompson P.M. Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia 2008, 46:1597-1612.
2. Avants B.B., Epstein C.L., Grossman M., Gee J.C. Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain. Med. Image Anal. 2008, 12:26-41.
3. Badea A., Johnson G., Jankowsky J. Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease. Neuroimage 2010, 50:416-427.
4. Berezovska O., Jack C., Deng A., Gastineau N., Rebeck G.W., Hyman B.T. Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent gamma-secretase cleavage. J.Biol. Chem. 2001, 276:30018-30023.
5. Bock N.A., Konyer N.B., Henkelman R.M. Multiple-mouse MRI. Magn. Reson. Med. 2003, 49:158-167.
6. Born H.A., Kim J.Y., Savjani R.R., Das P., Dabaghian Y.A., Guo Q., Jankowsky J.L. Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzeimer's disease. J.Neurosci. 2014, 34:3826-4380.
7. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
8. Cahill L.S., Laliberté C.L., Ellegood J., Spring S., Gleave J.A., Eede M.C., Lerch J.P., Henkelman R.M. Preparation of fixed mouse brains for MRI. Neuroimage 2012, 60:933-939.
9. Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., Sabatini D.M. CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006, 7:R100.
10. Chételat G., Villemagne V.L., Bourgeat P., Pike K.E., Jones G., Ames D., Rowe C.C. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann. Neurol. 2010, 67:317-324.
11. Chishti M.A., Yang D., Janus C., Phinney A.L., Horne P., Pearson J., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J.Biol. Chem. 2001, 276:21562-21570.
12. Collins D.L., Holmes C.J., Peters T.M., Evans A.C. Automatic 3-D model-based neuroanatomical segmentation. Hum. Brain Mapp. 1995, 3:190-208.
13. Collins D.L., Neelin P., Peters T.M., Evans A. Automatic 3D intersubject registration of MR volumetric data in standardized talairach space.pdf. J.Comput. Assist. Tomogr. 1994, 18:192-205.
14. Delatour B., Guégan M., Volk A., Dhenain M. Invivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol. Aging 2006, 27:835-847.
15. Dorr A., Sahota B., Chinta L.V., Brown M.E., Lai A.Y., Ma K., Stefanovic B. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain 2012, 135:3039-3050.
16. Dudal S., Krzywkowski P., Paquette J., Morissette C., Lacombe D., Tremblay P., Gervais F. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol. Aging 2004, 25:861-871.
17. Ferreira S.T., Klein W.L. The Ab oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol. Learn. Mem. 2011, 96:529-543.
18. Gazdzinski L.M., Cormier K., Lu F.G., Lerch J.P., Wong C.S., Nieman B.J. Radiation-induced alterations in mouse brain development characterized by magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84:e631-e638.
19. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878.
20. Grand'maison M., Zehntner S.P., Ho M.K., Hébert F., Wood A., Carbonell F., Bedell B.J. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease. Neurobiol. Dis. 2013, 54:59-67.
21. Hébert F., Grand'maison M., Ho M.K., Lerch J.P., Hamel E., Bedell B.J. Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 2012, 34:1-9.
22. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., Celio M.R. Comparative cytoarchitectonic atlas of the C57BL/6 and 129/SV mouse brains 2000, Elsevier Science B.V., Amsterdam, Netherlands.
23. Hsiao K.K., Borchelt D.R., Olson K., Johannsdottir R., Kitt C., Yunis W., Price D. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 1995, 15:1203-1218.
24. Iadecola C., Zhang F., Niwa K., Eckman C., Turner S.K., Fischer E., Carlson G.A. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 1999, 2:157-161.
25. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., Klein W.L. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J.Neurosci. 2007, 27:796-807.
26. Lalonde R., Fukuchi K., Strazielle C. Neurologic and motor dysfunctions in APP transgenic mice. Rev. Neurosci 2012, 23:363-379.
27. Lau J.C., Lerch J.P., Sled J.G., Henkelman R.M., Evans A.C., Bedell B.J. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage 2008, 42:19-27.
28. Lehéricy S., Marjanska M., Mesrob L., Sarazin M., Kinkingnehun S. Magnetic resonance imaging of Alzheimer's disease. Eur. Radiol. 2007, 17:347-362.
29. Lerch J.P., Sled J.G., Henkelman R.M. MRI phenotyping of genetically altered mice. Methods Mol. Biol. 2011, 711:349-361.
30. Lerch J.P., Yiu A.P., Martinez-Canabal A., Pekar T., Bohbot V.D., Frankland P.W., Sled J.G. Maze training in mice induces MRI-detectable brain shape changes specific to the type of learning. Neuroimage 2011, 54:2086-2095.
31. Maheswaran S., Barjat H., Bate S.T., Aljabar P., Hill D.L., Tilling L., Rueckert D. Analysis of serial magnetic resonance images of mouse brains using image registration. Neuroimage 2009, 44:692-700.
32. Mcevoy L.K., Fennema-Notestine C., Roddey J.C., Hagler D.J., Holland D., Karow D.S., Dale A.M. Alzheimer disease: Quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Neuroradiology 2009, 251:195-205.
33. Mucke L., Masliah E., Johnson W.B., Ruppe M.D., Alford M., Rockenstein E.M., Abraham C.R. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res. 1994, 666:151-167.
34. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005, 50:427-434.
35. Pinheiro J.C., Bates D.M. Mixed-Effects Models in S and S-Plus 2009, Springer-Verlag, New York.
36. Redwine J.M., Kosofsky B., Jacobs R.E., Games D., Reilly J.F., Morrison J.H., Bloom F.E. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1381-1386.
37. Selkoe D., Kopan R. Notch and Presenilin: Regulated intramembrane proteolysis links development and degeneration. Annu. Rev. Neurosci. 2003, 26:565-597.
38. Silva A.C., Bock N.A. Manganese-enhanced MRI: An exceptional tool in translational neuroimaging. Schizophr Bull. 2008, 34:595-604.
39. Silva A.C., Lee J.H., Aoki I., Koretsky A.P. Manganese-enhanced magnetic resonance imaging (MEMRI): Methodological and practical considerations. NMR Biomed. 2004, 17:532-543.
40. Simón A.M., Schiapparelli L., Salazar-Colocho P., Cuadrado-Tejedor M., Escribano L., López de Maturana R., Frechilla D. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol. Dis. 2009, 33:369-378.
41. Smith K.D.B., Kallhoff V., Zheng H., Pautler R.G. Invivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 2007, 35:1401-1408.
42. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
43. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
44. Steele J.W., Brautigam H., Short J.A., Sowa A., Shi M., Yadav A., Dickstein D.L. Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model. J.Comp. Neurol. 2014, 522:2319-2335.
45. Sussman D., Ellegood J., Henkelman M. Agestational ketogenic dietalters maternal metabolic status as well as offspring physiological growth and brain structure in the neonatal mouse. BMC Pregnancy Childbirth 2013, 13:198.
46. Thiessen J.D., Glazner K.A.C., Nafez S., Schellenberg A.E., Buist R., Martin M., Albensi B.C. Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease. Brain Struct. Funct. 2010, 215:29-36.
47. Woodhouse A., Vickers J.C., Adlard P.A., Dickson T.C. Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging. Neurobiol. Aging 2009, 30:864-874.
48. Wyss-Coray T. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response?. Nat. Med. 2006, 12:1005-1015.
49. Zhang J., Richards L.J., Miller M.I., Yarowsky P., van Zijl P., Mori S. Characterization of mouse brain and its development using diffusion tensor imaging and computational techniques. Eng. Med. Biol. Soc. Conf. 2006, 1:2252-2255.
50. Zheng H., Koo E.H. The amyloid precursor protein: Beyond amyloid. Mol. Neurodegener. 2006, 1:5.
51. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28:202-208.
52. Zoghbi H.Y., Bear M.F. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb. Perspect. Biol. 2012, 4:1-22.